Q-line Biotech Ltd PE Ratio

Q-line Biotech PE Ratio

Image

Q-Line Biotech Ltd

NSE: Q-LineBiotech

PE

23.2

Last updated on: Jun 19, 2026

Key Highlights

  • The P/E Ratio of Q-Line Biotech Ltd is 23.2 as of 19 Jun 15:30 PM The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2023 to 0 on March 2025 . This represents a CAGR of 0.0% over 3 years The Latest Trading Price of Q-Line Biotech Ltd is ₹ 562.6 as of 19 Jun 15:30 The PE Ratio of Trading Industry has changed from 115.1 to 66.1 in 5 years. This represents a CAGR of -10.50% The PE Ratio of Automobile industry is 36.7. The PE Ratio of Finance industry is 33.2. The PE Ratio of IT - Software industry is 18.2. The PE Ratio of Retail industry is 67.8. The PE Ratio of Textiles industry is 23.9. The PE Ratio of Trading industry is -76.4 in 2026 .

Historical P/E Ratio of Q-Line Biotech Ltd

No data available

Company Fundamentals for Q-Line Biotech Ltd

Image

Q-Line Biotech Ltd

NSE: Q-LineBiotech

Share Price

₹ 562.6

36.75 (6.99%)

stock direction

Last updated on: Jun 19, 2026

Market Price of Q-Line Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Q-Line Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
19 Jun 2026562.6
18 Jun 2026525.85
17 Jun 2026509.65
16 Jun 2026502.15
15 Jun 2026508.3
12 Jun 2026509.3
11 Jun 2026504.35
10 Jun 2026483.35
09 Jun 2026508.75
08 Jun 2026514.55

BlinkX Score for Q-Line Biotech Ltd

Asset Value vs Market Value of Q-Line Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Q-Line Biotech Ltd1312
Adani Enterprises Ltd395202
Premier Energies Ltd49004
Aegis Logistics Ltd35395
Redington Ltd21960
Honasa Consumer Ltd13616

PE Ratio of Q-Line Biotech Ltd Explained

1312

Market cap

34

Earnings

23.2X

PE Ratio

PE Ratio of Trading Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Q-Line Biotech Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Q-Line Biotech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Q-Line Biotech Ltd

No data available

* All values are in %

About Q-Line Biotech Ltd

  • Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
  • Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
  • Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

Q-Line Biotech Ltd News Hub

NSE SME Q-Line Biotech lands on Dalal Street with a strong pulse

The scrip was listed at Rs 452, a 31.78% premium to the initial public offer (IPO) price. The stock

Read more

29 May 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of null

What is the current PE Ratio of Q-Line Biotech Ltd?

The Current PE Ratio of Q-Line Biotech Ltd is 23.24 as on 19 Jun 2026.

What is the average PE Ratio of the Trading industry?

The average industry PE Ratio of Trading is -76.4 as on 19 Jun 2026.

What was the PE Ratio of Q-Line Biotech Ltd last year?

The PE Ratio of Q-Line Biotech Ltd was 0.0 last year, now the PE ratio is 23.24, showing a year-on-year growth of -%.

What does the PE Ratio of Q-Line Biotech Ltd indicate about its stock?

The PE Ratio of Q-Line Biotech Ltd is 23.24. This ratio indicates that investors are willing to pay 23.24 times the earnings per share for each share of Q-Line Biotech Ltd.

What is the PE Ratio Growth of Q-Line Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Q-Line Biotech Ltd grew by -% whereas, the EPS ratio grew by -2.1.

How does the PE ratio of Q-Line Biotech Ltd compare to industry peers?

The PE ratio of Q-Line Biotech Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Q-Line Biotech Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Q-Line Biotech Ltd PE Ratio.

What factors influence the PE ratio of Q-Line Biotech Ltd PE Ratio?

The PE ratio of Q-Line Biotech Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Q-Line Biotech Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Q-Line Biotech Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Q-Line Biotech Ltd PE Ratio?

You can check the latest PE ratio of Q-Line Biotech Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Q-Line Biotech Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Q-Line Biotech Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Q-Line Biotech Ltd PE Ratio predict future stock performance?

While the Q-Line Biotech Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions